125 related articles for article (PubMed ID: 17349625)
1. Leishmania amazonensis: humoral response to amastigote excreted-antigens in murine leishmaniasis.
Hernández-Chinea C
Exp Parasitol; 2007 Aug; 116(4):492-6. PubMed ID: 17349625
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis.
Webb JR; Kaufmann D; Campos-Neto A; Reed SG
J Immunol; 1996 Dec; 157(11):5034-41. PubMed ID: 8943412
[TBL] [Abstract][Full Text] [Related]
3. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
Mukherjee M; Bhattacharyya A; Duttagupta S
Med Sci Monit; 2002 Apr; 8(4):BR117-22. PubMed ID: 11951057
[TBL] [Abstract][Full Text] [Related]
4. Different patterns of disease in two inbred mouse strains infected with a clone of Leishmania mexicana amazonensis.
Barral-Netto M; Cardoso SA; Barral A
Acta Trop; 1987 Mar; 44(1):5-11. PubMed ID: 2884839
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies specific for the amastigote stage of Leishmania pifanoi. I. Characterization of antigens associated with stage- and species-specific determinants.
Pan AA; McMahon-Pratt D
J Immunol; 1988 Apr; 140(7):2406-14. PubMed ID: 2450920
[TBL] [Abstract][Full Text] [Related]
6. Humoral immune responses among mucosal and cutaneous leishmaniasis patients caused by Leishmania braziliensis.
Valli LC; Passos VM; Dietze R; Callahan HL; Berman JD; Grogl M
J Parasitol; 1999 Dec; 85(6):1076-83. PubMed ID: 10647040
[TBL] [Abstract][Full Text] [Related]
7. Isotype profiles of Leishmania donovani-infected BALB/c mice: preferential stimulation of IgG2a/b by liposome-associated promastigote antigens.
Afrin F; Ali N
J Parasitol; 1998 Aug; 84(4):743-8. PubMed ID: 9714204
[TBL] [Abstract][Full Text] [Related]
8. Vaccination of different strains of mice against cutaneous leishmaniosis: usefulness of membrane antigens encapsulated into liposomes by intraperitoneal and subcutaneous administration.
Lezama-Dávila CM
Arch Med Res; 1997; 28(1):47-53. PubMed ID: 9078587
[TBL] [Abstract][Full Text] [Related]
9. Immune serum from both susceptible and resistant strains of mice increases phagocytosis of Leishmania mexicana amazonensis by macrophages.
Reis MG; Roters SB; Barral-Netto M
Acta Trop; 1987 Sep; 44(3):339-42. PubMed ID: 2892370
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of DNA vaccines encoding various antigens against Leishmania mexicana.
Dumonteil E; Andrade-Narvarez F; Escobedo-Ortegon J; Ramirez-Sierra MJ; Valencia-Pacheco G; Flores-Serrano A; Canto-Lara S; Arjona-Torres A
Dev Biol (Basel); 2000; 104():135-41. PubMed ID: 11713811
[TBL] [Abstract][Full Text] [Related]
11. Leishmania amazonensis: cultivation and characterization of axenic amastigote-like organisms.
Hodgkinson VH; Soong L; Duboise SM; McMahon-Pratt D
Exp Parasitol; 1996 Jun; 83(1):94-105. PubMed ID: 8654556
[TBL] [Abstract][Full Text] [Related]
12. In vitro maintenance of Leishmania amastigotes directly from lesions: advantages and limitations.
Hodgkinson VH; Soong L
J Parasitol; 1997 Oct; 83(5):953-6. PubMed ID: 9379307
[TBL] [Abstract][Full Text] [Related]
13. Histopathologic changes induced by vaccination in experimental cutaneous leishmaniasis of BALB/c mice.
Barral-Netto M; de Freitas LA; Andrade ZA
Am J Pathol; 1987 May; 127(2):271-8. PubMed ID: 3495185
[TBL] [Abstract][Full Text] [Related]
14. Infection of BALB/c, C57B1/6 mice and F1 hybrid CB6F1 mice with strains of Leishmania mexicana isolated from Mexican patients with localized or diffuse cutaneous leishmaniasis.
Monroy-Ostria A; Fuentes-Fraga I; García-Flores C; Favila-Castillo L
Arch Med Res; 1994; 25(4):401-6. PubMed ID: 7858398
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB/c and C57BL/6 mice against cutaneous leishmaniasis.
Pinto EF; de Mello Cortezia M; Rossi-Bergmann B
Vaccine; 2003 Sep; 21(25-26):3534-41. PubMed ID: 12922080
[TBL] [Abstract][Full Text] [Related]
16. Identification and molecular characterization of a gene encoding a protective Leishmania amazonensis Trp-Asp (WD) protein.
Campbell K; Popov V; Soong L
Infect Immun; 2004 Apr; 72(4):2194-202. PubMed ID: 15039343
[TBL] [Abstract][Full Text] [Related]
17. An essential role for IL-13 in maintaining a non-healing response following Leishmania mexicana infection.
Alexander J; Brombacher F; McGachy HA; McKenzie AN; Walker W; Carter KC
Eur J Immunol; 2002 Oct; 32(10):2923-33. PubMed ID: 12355446
[TBL] [Abstract][Full Text] [Related]
18. [Production of monoclonal antibodies against Leishmania mexicana mexicana antigens].
Correnti M; Ortega G
Acta Cient Venez; 1991; 42(4):226-8. PubMed ID: 1843566
[TBL] [Abstract][Full Text] [Related]
19. Immune response and protection in mice inoculated with Leishmania amazonensis clones expressing different degrees of virulence.
da Fonseca AL; Vallochi AL; Furtado Gde C; Abrahamsohn Ide A; Lima GM
Parasitol Res; 1997; 83(7):690-7. PubMed ID: 9272560
[TBL] [Abstract][Full Text] [Related]
20. Immune responses induced by a Leishmania (Leishmania) amazonensis recombinant antigen in mice and lymphocytes from vaccinated subjects.
Fernandes AP; Herrera EC; Mayrink W; Gazzinelli RT; Liu WY; de Costa CA; Tavares CA; Melo MN; Michalick MS; Gentz R; Nascimento E
Rev Inst Med Trop Sao Paulo; 1997; 39(2):71-8. PubMed ID: 9394518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
